Company Filing History:
13 out of 1,863 
1 out of 1 Years Active: 2014-2025
Title: Changfeng Tai: Innovator in Neuromodulation Technology
Introduction: Changfeng Tai, based in Wexford, PA, is a prolific inventor with an impressive portfolio of 11 patents. His work primarily focuses on developing innovative therapies for treating bladder and bowel dysfunction through advanced neuromodulation techniques.
Latest Patents: Among his latest contributions to the field, Tai has developed two notable patents. The first patent details methods for treating underactive bladder, urinary retention, detrusor-sphincter dyssynergia after spinal cord injury, constipation, and infrequent bowel movements. This method involves applying electrical stimulation to one or more peripheral nerves, showcasing the potential of neuromodulation in enhancing quality of life for individuals with these conditions. The second patent addresses a technique for blocking nerve conduction or neuron excitation via electrical stimulation at sub-threshold intensity, providing a breakthrough in pain management and nerve function modulation.
Career Highlights: Changfeng Tai has established himself as a leading figure in the field of biomedical engineering through his research and innovations. His tenure at the University of Pittsburgh has enabled him to collaborate with a diverse group of professionals and contribute significantly to advancements in neuromodulation technology.
Collaborations: Throughout his career, Tai has worked closely with notable colleagues, including Michael B. Chancellor. These collaborations have fostered a rich environment for interdisciplinary research, enhancing the development and application of novel medical therapies.
Conclusion: Changfeng Tai's contributions to the field of neuromodulation exemplify the impact of innovation and research in improving healthcare outcomes. With his ongoing work at the University of Pittsburgh, he continues to drive advancements that have the potential to transform the treatment of bladder and bowel dysfunction, marking him as a key inventor to watch in the evolving landscape of medical technology.